7.50 USD
↘ 0.52 (6.48%)AT CLOSE (11:59 AM EDT)
Oric Pharmaceuticals, Inc. Common Stock
ORICNASDAQ • USD
7.95
↗ 0.45 (6.03%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
7.95
↗ 0.45 (6.03%)
Market: CLOSED
Open?$8.00
High?$8.12
Low?$7.48
Prev. Close?$8.02
Volume?1.2M
Avg. Volume?1.5M
VWAP?$7.77
Rel. Volume?0.81x
Bid / Ask
Bid?$7.32 × 3.0K
Ask?$8.58 × 100
Spread?$1.26
Midpoint?$7.95
Valuation & Ratios
Market Cap?776.4M
Shares Out?103.5M
Float?58.1M
Float %?59.7%
P/E Ratio?N/A
P/B Ratio?1.87
EPS?-$1.31
Dividend?0.00%
Ex-Dividend?N/A
Shares of Oric Pharmaceuticals, Inc. Common Stock (ORIC) are trading at $7.50. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Employees
104
Market Cap
776.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-04-24
Address
240 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 388-5600
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 388-5600
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?30
Piotroski F-Score?0/9Weak
Altman Z-Score?19.25Safe
Confidence?45%Low
Short InterestSqueeze Risk
Short % of Float?37.77%Squeeze Risk
Short Interest?21.9M
Days to Cover?15.4
Free Float58.1M
Avg Daily Volume1.4M
Settlement Date2026-05-15
Financial Health
Current Ratio?16.33Strong
Quick Ratio?16.33Strong
Cash Ratio?3.17Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.87CHEAP▾
Peers100
S&P78
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-32.5%WEAK▾
S&P6
ROA?-31.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-111202000
Enterprise Value?$720.0M
Fundamentals ratios updated end of day